-
Something wrong with this record ?
Effect of procathepsin D activation peptide on gene expression of breast cancer cells
Benes P, Vashishta A, Saraswat-Ohri S, Fusek M, Pospisilova S, Tichy B, Vetvicka V.
Language English Country Ireland
Grant support
NR8448
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
ScienceDirect (archiv)
from 1993-01-01 to 2009-12-31
- MeSH
- Financing, Organized MeSH
- Cathepsin D pharmacology MeSH
- Humans MeSH
- Tumor Cells, Cultured MeSH
- Neoplasm Proteins genetics MeSH
- Breast Neoplasms genetics MeSH
- NF-kappa B p52 Subunit genetics metabolism MeSH
- Peptide Fragments pharmacology MeSH
- Reverse Transcriptase Polymerase Chain Reaction MeSH
- Enzyme Precursors pharmacology MeSH
- Gene Expression Regulation, Neoplastic drug effects MeSH
- Oligonucleotide Array Sequence Analysis MeSH
- Signal Transduction MeSH
- Gene Expression Profiling MeSH
- Check Tag
- Humans MeSH
Overexpression of procathepsin D (pCD) is reported to occur in numerous types of cancer and is associated with increased growth and metastasis. It has been established that pCD affects multiple stages of tumor progression including proliferation, angiogenesis and metastasis. Previously, we showed that the mitogenic effect of pCD on cancer cells is mediated by interaction of its activation peptide (AP) with yet unidentified cell surface receptor. In this investigation, gene expression profiles were compared between AP-treated and control human breast cancer ZR-75-1 cells to elucidate the mechanism of AP mitogenicity. Several differentially expressed genes involved in signal transduction, regulation of cell cycle, apoptosis, tumor invasion and metastasis were identified using microarray technology. These findings, including overexpression of NF-kappaB2, were confirmed in breast cancer cell lines by reverse-transcriptase PCR (RT-PCR). Understanding the mechanism of pCDs effect on breast cancer cells could extend possibilities of breast cancer treatment in the future.
- 000
- 00000naa 2200000 a 4500
- 001
- bmc07522650
- 003
- CZ-PrNML
- 005
- 20131002135920.0
- 008
- 090506s2006 ie e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ie
- 100 1_
- $a Beneš, Petr. $7 xx0208982
- 245 10
- $a Effect of procathepsin D activation peptide on gene expression of breast cancer cells / $c Benes P, Vashishta A, Saraswat-Ohri S, Fusek M, Pospisilova S, Tichy B, Vetvicka V.
- 314 __
- $a Department of Genetics and Molecular Biology, Faculty of Science, Masaryk University Brno, Kotlarska 2, Brno 61137, Czech Republic. pbenes@sci.muni.cz
- 520 9_
- $a Overexpression of procathepsin D (pCD) is reported to occur in numerous types of cancer and is associated with increased growth and metastasis. It has been established that pCD affects multiple stages of tumor progression including proliferation, angiogenesis and metastasis. Previously, we showed that the mitogenic effect of pCD on cancer cells is mediated by interaction of its activation peptide (AP) with yet unidentified cell surface receptor. In this investigation, gene expression profiles were compared between AP-treated and control human breast cancer ZR-75-1 cells to elucidate the mechanism of AP mitogenicity. Several differentially expressed genes involved in signal transduction, regulation of cell cycle, apoptosis, tumor invasion and metastasis were identified using microarray technology. These findings, including overexpression of NF-kappaB2, were confirmed in breast cancer cell lines by reverse-transcriptase PCR (RT-PCR). Understanding the mechanism of pCDs effect on breast cancer cells could extend possibilities of breast cancer treatment in the future.
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a nádory prsu $x genetika $7 D001943
- 650 _2
- $a kathepsin D $x farmakologie $7 D002402
- 650 _2
- $a prekurzory enzymů $x farmakologie $7 D004792
- 650 _2
- $a stanovení celkové genové exprese $7 D020869
- 650 _2
- $a regulace genové exprese u nádorů $x účinky léků $7 D015972
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a NF-kappa B - podjednotka p52 $x genetika $x metabolismus $7 D052003
- 650 _2
- $a nádorové proteiny $x genetika $7 D009363
- 650 _2
- $a sekvenční analýza hybridizací s uspořádaným souborem oligonukleotidů $7 D020411
- 650 _2
- $a peptidové fragmenty $x farmakologie $7 D010446
- 650 _2
- $a polymerázová řetězová reakce s reverzní transkripcí $7 D020133
- 650 _2
- $a signální transdukce $7 D015398
- 650 _2
- $a nádorové buňky kultivované $7 D014407
- 700 1_
- $a Vashishta, Aruna
- 700 1_
- $a Saraswat, Ohri Sujata
- 700 1_
- $a Fusek, Martin, $d 1958- $7 jo2007286435
- 700 1_
- $a Pospíšilová, Šárka, $d 1969- $7 xx0101843
- 700 1_
- $a Tichý, Boris. $7 xx0312236
- 700 1_
- $a Větvička, Václav, $d 1954- $7 skuk0001572
- 773 0_
- $w MED00001044 $t Cancer letters $g Roč. 239, č. 1 (2006), s. 46-54 $x 0304-3835
- 910 __
- $a ABA008 $b x $y 9
- 990 __
- $a 20090310084605 $b ABA008
- 991 __
- $a 20131002140437 $b ABA008
- 999 __
- $a ok $b bmc $g 650742 $s 503905
- BAS __
- $a 3
- BMC __
- $a 2006 $b 239 $c 1 $d 46-54 $i 0304-3835 $m Cancer letters $x MED00001044
- GRA __
- $a NR8448 $p MZ0
- LZP __
- $a 2009-B3/ipme